Literature DB >> 9166274

Long-term prognosis for patients with chronic leg ulcers: a prospective cohort study.

O Nelzén1, D Bergqvist, A Lindhagen.   

Abstract

OBJECTIVES: To assess the long-term prognosis of leg ulcers.
DESIGN: A 5 year prospective cohort study. MATERIALS: A random sample of 382 patients with open leg ulcers (foot ulcers included) treated in the community.
METHODS: Interim analyses were made at 15 months (arterial ulcers) and at 20 months (varicose ulcers). Long-term healing was assessed at 54 months by a postal questionnaire. Five year survival was assessed by official population registries.
RESULTS: At 54 months 212 patients (55%) were still alive, of whom 124 (58%) had healed their ulcers, 80 (38%) had open ulcers and eight (4%) were amputated. The healing was worst for patients with venous ulcers, only 44% had healed their original ulcers without recurrence. The 5 year survival was 52%, significantly lower than for age- and sex-matched controls (68%) (p = 0.0002). Patients with venous ulcers had a survival not significantly different from controls and patients with arterial or other aetiologies had a doubled risk of death. Diabetic patients had a lower survival than non-diabetics (p < 0.05) and controls (p < 0.0001), but the healing prognosis was not significantly different.
CONCLUSION: Only patients with non-venous ulcers have a higher mortality than expected. The long-term healing prognosis for leg ulcer patients is poor and worst for patients with venous ulcers.

Entities:  

Mesh:

Year:  1997        PMID: 9166274     DOI: 10.1016/s1078-5884(97)80179-7

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  19 in total

Review 1.  Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids.

Authors:  Katherine A Lyseng-Williamson; Caroline M Perry
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 2.  Association Between Microbial Bioburden and Healing Outcomes in Venous Leg Ulcers: A Review of the Evidence.

Authors:  Marie S Tuttle
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-01-01       Impact factor: 4.730

3.  Patient-level estimates of the cost of complications in diabetes in a managed-care population.

Authors:  S D Ramsey; K Newton; D Blough; D K McCulloch; N Sandhu; E H Wagner
Journal:  Pharmacoeconomics       Date:  1999-09       Impact factor: 4.981

Review 4.  Preventing venous ulcer recurrence: a review.

Authors:  Kathryn R Vowden; Peter Vowden
Journal:  Int Wound J       Date:  2006-03       Impact factor: 3.315

5.  Protocol for a pilot randomised controlled clinical trial to compare the effectiveness of a graduated three layer straight tubular bandaging system when compared to a standard short stretch compression bandaging system in the management of people with venous ulceration: 3VSS2008.

Authors:  Carolina D Weller; Sue Evans; Christopher M Reid; Rory Wolfe; John McNeil
Journal:  Trials       Date:  2010-03-09       Impact factor: 2.279

6.  Five-year outcomes of patients attending a diabetic foot clinic in a tertiary referral centre.

Authors:  Hannah Forde; Sarah Wrigley; Liam Tomas O'Murchadha; Lyn Cusack; Sinead Casserly; Daragh Moneley; James Walsh; Diarmuid Smith
Journal:  Ir J Med Sci       Date:  2019-10-24       Impact factor: 1.568

7.  Role of hospital anxiety and depression on the healing of chronic leg ulcer: A prospective study.

Authors:  Navin Kumar; Farhanul Huda; Rishit Mani; Tanuj Singla; Ashikesh Kundal; Jyoti Sharma; Bhargav Gajula
Journal:  Int Wound J       Date:  2020-08-26       Impact factor: 3.315

8.  Compression Stockings for the Prevention of Venous Leg Ulcer Recurrence: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2019-02-19

9.  Long-term Mortality among Patients with Chronic Ulcers.

Authors:  Jenni E Salenius; Minna Suntila; Tiina Ahti; Heini Huhtala; Annikki Vaalasti; Teea T Salmi; Teija Kimpimäki
Journal:  Acta Derm Venereol       Date:  2021-05-19       Impact factor: 3.875

10.  Skin Substitutes for Adults With Diabetic Foot Ulcers and Venous Leg Ulcers: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.